Tokyo, Nov. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059647) titled 'The feasibility study for pancreatic cancer screening by plasma biomarker using Enzeavour Pancreatic Cancer Test' on Nov. 5.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Cosomil Inc.
Condition:
Condition - Pancreatic cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This feasibility study is intended to support the implementation of a future large randomized controlled trial (RCT) evaluating the utility of the Enzeavo...